Have a personal or library account? Click to login
How Reliable Is Ultrasound for Detection and Follow Up on Breast Cancer Liver Metastases? Cover

How Reliable Is Ultrasound for Detection and Follow Up on Breast Cancer Liver Metastases?

Open Access
|Mar 2025

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49. https://doi.org/10.3322/caac.21660 PMid:33538338
  2. Lourenço, C.; Conceição, F.; Jerónimo, C.; Lamghari, M.; Sousa, D.M. Stress in Metastatic Breast Cancer: To the Bone and Beyond. Cancers 2022, 14, 1881. https://doi.org/10.3390/cancers14081881 PMid:35454788 PMCid:PMC9028241
  3. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394-424. https://doi.org/10.3322/caac.21492 PMid:30207593
  4. Wu, Q.; Li, J.; Zhu, S.; Wu, J.; Chen, C.; Liu, Q.; Wei, W.; Zhang, Y.; Sun, S. Breast cancer subtypes predict the preferential site of distant metastases: A SEER based study. Oncotarget 2017, 8, 27990-27996. https://doi.org/10.18632/oncotarget.15856 PMid:28427196 PMCid:PMC5438624
  5. Buonomo, O.C.; Caredda, E.; Portarena, I.; Vanni, G.; Orlandi, A.; Bagni, C.; Petrella, G.; Palombi, L. New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes. PLoS ONE 2017, 12, e0184680. https://doi.org/10.1371/journal.pone.0184680 PMid:28922402 PMCid:PMC5602519
  6. Almubarak, M.M.; Laé, M.; Cacheux, W.; de Cremoux, P.; Pierga, J.-Y.; Reyal, F.; Bennett, S.P.; Falcou, M.-C.; Salmon, R.J.; Baranger, B.; et al. Gastric metastasis of breast cancer: A single centre retrospective study. Dig. Liver Dis. 2011, 43, 823-827. https://doi.org/10.1016/j.dld.2011.04.009 PMid:21616731
  7. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, Allen-Mersh TG. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum. 2002;45:476-484. https://doi.org/10.1007/s10350-004-6224-y PMid:12006929
  8. Xu LH, Cai SJ, Cai GX, Peng WJ. Imaging diagnosis of colorectal liver metastases. World J Gastroenterol. 2011;17:4654-4659. https://doi.org/10.3748/wjg.v17.i42.4654 PMid:22180707 PMCid:PMC3237298
  9. Cantisani V, Grazhdani H, Fioravanti C, Rosignuolo M, Calliada F, Messineo D, Bernieri MG, Redler A, Catalano C, D’Ambrosio F. Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance. World J Gastroenterol. 2014;20:9998-10007. https://doi.org/10.3748/wjg.v20.i29.9998 PMid:25110428 PMCid:PMC4123379
  10. Matos AP, Altun E, Ramalho M, Velloni F, AlObaidy M, Semelka RC. An overview of imaging techniques for liver metastases management. Expert Rev Gastroenterol Hepatol. 2015;9:1561-1576. https://doi.org/10.1586/17474124.2015.1092873 PMid:26414180
  11. Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol. 2011;79:e1-e6. https://doi.org/10.1016/j.ejrad.2010.03.004 PMid:20392584
  12. Sahani DV, Bajwa MA, Andrabi Y, Bajpai S, Cusack JC. Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma. Ann Surg. 2014;259:861-872. https://doi.org/10.1097/SLA.0000000000000525 PMid:24509207
  13. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol. 2000;174:691-698. https://doi.org/10.2214/ajr.174.3.1740691 PMid:10701611
  14. Matos AP, Altun E, Ramalho M, Velloni F, AlObaidy M, Semelka RC. An overview of imaging techniques for liver metastases management. Expert Rev Gastroenterol Hepatol. 2015;9:1561-1576. https://doi.org/10.1586/17474124.2015.1092873 PMid:26414180
  15. Lincke T, Zech CJ. Liver metastases: Detection and staging. Eur J Radiol. 2017;97:76-82. https://doi.org/10.1016/j.ejrad.2017.10.016 PMid:29153371
  16. Gore RM, Thakrar KH, Wenzke DR, Newmark GM, Mehta UK, Berlin JW. That liver lesion on MDCT in the oncology patient: is it important? Cancer Imaging. 2012;12:373-384. https://doi.org/10.1102/1470-7330.2012.9028 PMid:23023318 PMCid:PMC3485646
  17. Kamaya A, Maturen KE, Tye GA, Liu YI, Parti NN, Desser TS. Hypervascular liver lesions. Semin Ultrasound CT MR. 2009;30:387-407. https://doi.org/10.1053/j.sult.2009.06.001 PMid:19842564
  18. Bruneton JN, Balu-Maestro C, Raffaelli C, Mourou MY, Cambon P, Granon C. Indications for hepatic ultrasonography in breast cancer staging and follow-up. Breast Cancer Res Treat. 1996;37(2):115-21. https://doi.org/10.1007/BF01806493 PMid:8750579
  19. Francis IR, Cohan RH, McNulty NJ, Platt JF, Korobkin M, Gebremariam A, Ragupathi KI. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol. 2003 May;180(5):1217-24. doi: 10.2214/ajr.180.5.1801217. Erratum in: AJR Am J Roentgenol. 2003 Jul;181(1):283. https://doi.org/10.2214/ajr.180.5.1801217 PMid:12704026
Language: English
Page range: 14 - 18
Submitted on: Oct 2, 2024
|
Accepted on: Dec 17, 2024
|
Published on: Mar 15, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Gabriela Dimova, Marija Karakolevska-Ilova, Antonio Gligorievski, published by Scientific Foundation SPIROSKI
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.